Interestingly, the Znt7-knockout increased tumorigenesis in a transgenic mouse model of prostate adenocarcinoma (TRAMP/Znt7−/−), indicating that a reduced expression of this gene might contribute to tumor progression. Here, SLC30A7 is linked to prostate adenocarcinoma.